iSERA Lifesciences Ltd. Stock price: Live updates

₹143.9

0% (0)

Market Cap

₹121 Cr.

P/E

465.40

Key Ratios

Edit Ratio's

Market cap

121 Cr

465

Prom Holding

58.63 %

ROE (%)

ROCE (%)

9.22

Div Yield (%)

Sales

1.35 Cr

OPM (%)

19.78 %

Debt to Equity

-16.38

Institutions

Individual < 2 lac

12.65 %

No. of Shareholders

1,029

Edit Ratio's

About

Aptus Industries Limited is a Public Limited Company and engaged in handling of Agricultural S… Read more

Low

52W Range

High

144

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

Edit rows

Forensics

6 Yes

Positive for this company

2 Neutral

Neutral for this company

4 No

Negative for this company

4 No Data

Insufficient data to analyse

Accounting & Shareholding

Depreciation Effect

Depreciation accounting is not leading to increase in profits
Pledge

Promoters have not pledged a significant portion of their holding
Retail Holding

Retail has been selling the stock which is usually a good time to buy
Revenue Recognition

Company is converting accounting profit to cash
Promoter Holding

Promoter has not sold any shares in the last 90 days
Contingent Liabilities

Unable to calculate due to limited data
Other Income

Unable to calculate due to limited data

Price & Performance

Capex vs ROCE

Roce of the company has increased over the last three years
Share price

Share price has increased over last 10 years due to earnings
Balance Sheet Strength

Balance sheet of the company is strong. but it might have issues paying it suppliers
Debt

Company might have issues servicing its debt
Working Capital

Company has significant working capital which is dragging its roce and roe
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong
Current vs Historic Valuation

Unable to calculate due to limited data
Sales Growth

Unable to calculate due to limited data

Revenue mix

Product Wise Break-Up

Peer Comparison

Corporate Actions

Consolidated

DATE

DETAILS

Show Less

FAQs on iSERA Lifesciences Ltd. Business

What does iSERA Lifesciences do?

Aptus Industries Limited, a Public Limited Company established in 1993, operates in agricultural software, construction, and infrastructure projects. Headquartered in Hyderabad, Andhra Pradesh.

Who are the competitors of iSERA Lifesciences?

iSERA Lifesciences major competitors are Xelpmoc Design &Tech, GVP Infotech, Canarys Automations, Elnet Technologies, WEP Solutions, California Software, Diensten Tech.
Market Cap of iSERA Lifesciences is ₹121 Crs.
While the median market cap of its peers are ₹123 Crs.

Is iSERA Lifesciences financially stable compared to its competitors?

iSERA Lifesciences seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

View FAQ's On Shareprice

Company Filing

	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary Powered by Claude

Discussions & Analysis

Ideas Dashboard

Results

Timeline

Watchlist

Portfolio

Alerts

Stock Screener

Market

Raw Material

iSERA Lifesciences Ltd.

iSERA Lifesciences Ltd.

Key Ratios

About

Timeline

Company Timeline

Custom financial statement

Forensics

6 Yes

2 Neutral

4 No

4 No Data

Accounting & Shareholding

Depreciation Effect

Pledge

Retail Holding

Revenue Recognition

Promoter Holding

Contingent Liabilities

Other Income

Price & Performance

Capex vs ROCE

Share price

Balance Sheet Strength

Debt

Working Capital

Margin Stability

ROCE Strength

Current vs Historic Valuation

Sales Growth

Revenue mix

Product Wise Break-Up

UNLOCK PREMIUM

Peer Comparison

Corporate Actions

FAQs on iSERA Lifesciences Ltd. Business

What does iSERA Lifesciences do?

Who are the competitors of iSERA Lifesciences?

Is iSERA Lifesciences financially stable compared to its competitors?

Company Filing

Discussions & Analysis

SIGN UP FOR FREE